Proteros biostructures has collaborated with Priaxon to develop lead compounds for high value protein-protein interaction (PPI) drug targets. The combination of Proteros' structure guided discovery with Priaxon's PPI-directed drug ...
Tags: Proteros, Priaxon Collaborate, PPI Drug
Priaxon has signed research collaboration with GlaxoSmithKline (GSK) to develop small molecule modulators for various protein-protein-interactions (PPIs). The collaboration will utilize Priaxon's small molecule drug discovery knowledge in ...
Tags: Priaxon, GSK, drug discovery, clinical development, therapeutic areas